5638-76-6 | 2-(2-Methylaminoethyl)pyridine

Packsize	Purity	Availability	Price	Discounted Price
1g	95%	in stock	$25.00	$18.00
5g	95%	in stock	$54.00	$38.00
10g	95%	in stock	$94.00	$66.00
25g	95%	in stock	$200.00	$140.00
100g	95%	in stock	$738.00	$517.00

Description

• Catalog Number: AB77577
• Chemical Name: 2-(2-Methylaminoethyl)pyridine
• CAS Number: 5638-76-6
• Molecular Formula: C8H12N2
• Molecular Weight: 136.1943
• MDL Number: MFCD00006362
• SMILES: CNCCc1ccccn1
• NSC Number: 42617

Computed Properties

• Complexity: 83.3
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 3
• XLogP3: 0.4

Upstream Synthesis Route

N-Methyl-2-pyridineethanamine, also known as $name$, is a versatile compound widely utilized in chemical synthesis. This compound serves as a crucial building block for the synthesis of various pharmaceuticals, agrochemicals, and specialty chemicals. In chemical synthesis, $name$ acts as a key intermediate in the production of complex molecules by facilitating the formation of new bonds and introducing functional groups. Its unique chemical properties make it a valuable component in the creation of diverse organic compounds, contributing significantly to the advancement of synthetic chemistry.

Literature

• Why are most phospholipidosis inducers also hERG blockers?

  Archives of toxicology 20171201

• Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability.

  British journal of pharmacology 20121001

• Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.

  Journal of psychopharmacology (Oxford, England) 20120901

• Involvement of histamine receptors in SAPK/JNK phosphorylation.

  International immunopharmacology 20120601

• Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.

  Clinical drug investigation 20120601

• Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.

  The Journal of laryngology and otology 20120401

• Meniere's disease: an evidence based approach to assessment and management.

  International journal of clinical practice 20120201

• Development of novel sustained release matrix pellets of betahistine dihydrochloride: effect of lipophilic surfactants and co-surfactants.

  Pharmaceutical development and technology 20120101

• The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20120101

• Duplicate internal auditory canals with facial and vestibulocochlear nerve dysfunction.

  The Journal of laryngology and otology 20120101

• Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo.

  PloS one 20120101

• Development and evaluation of sustained release tablet of betahistine hydrochloride using ion exchange resin tulsion t344.

  ISRN pharmaceutics 20120101

• [Efficacy of vestibo in the treatment of vertebrobasilar insufficiency].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101

• Vestibulary rehabilitation--election treatment method for compensating vestibular impairment.

  Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20120101

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Topical application of betahistine improves eustachian tube function in an animal model.

  Acta oto-laryngologica 20111101

• Current and future drug targets in weight management.

  Pharmaceutical research 20110801

• High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20110801

• Primary care for tinnitus: practice and opinion among GPs in England.

  Journal of evaluation in clinical practice 20110801

• Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus.

  Journal of neurology 20110701

• Synthesis, structures, and magnetic behavior of a series of copper(II) azide polymers of Cu4 building clusters and isolation of a new hemiaminal ether as the metal complex.

  Inorganic chemistry 20110418

• Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss.

  Journal of clinical pharmacology 20110401

• Management of acute idiopathic sensorineural hearing loss: a survey of UK ENT consultants.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20110401

• [Interdisciplinary approach to vestibular system impairment].

  Ideggyogyaszati szemle 20110330

• Which medication do I need to manage dizzy patients?

  Acta oto-laryngologica 20110301

• Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration.

  International journal of pharmaceutics 20110227

• Comparison of efficacy of different treatment methods in the treatment of idiopathic tinnitus.

  Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat 20110101

• [Prospects for the use of histaminergic preparations for the purpose of noise otoprotection].

  Vestnik otorinolaringologii 20110101

• Betahistine in the treatment of tinnitus in patients with vestibular disorders.

  Brazilian journal of otorhinolaryngology 20110101

• Prolonged vertigo and ataxia after mandibular nerve block for treatment of trigeminal neuralgia.

  Journal of anaesthesiology, clinical pharmacology 20110101

• [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

• An elderly female patient with tardive oromandibular dystonia after prolonged use of the histamine analog betahistine.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20101001

• Meniere's disease in the elderly.

  Otolaryngologic clinics of North America 20101001

• Allergy and its relation to Meniere's disease.

  Otolaryngologic clinics of North America 20101001

• Medical and noninvasive therapy for Meniere's disease.

  Otolaryngologic clinics of North America 20101001

• Medical management of Ménière's disease: a 10-year case series and review of literature.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20100901

• Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.

  The Journal of pharmacology and experimental therapeutics 20100901

• Does betahistine treatment have additional benefits to vestibular rehabilitation?

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20100801

• Case reports on two patients with episodic vertigo, fluctuating hearing loss and migraine responding to prophylactic drugs for migraine. Menière's disease or migraine-associated vertigo?

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20100801

• Neuropharmacology of vestibular system disorders.

  Current neuropharmacology 20100301

• Long-term course and relapses of vestibular and balance disorders.

  Restorative neurology and neuroscience 20100101

• Comprehensive analysis of MHC class I genes from the U-, S-, and Z-lineages in Atlantic salmon.

  BMC genomics 20100101

• Comparative bioavailability of betahistine tablet formulations administered in healthy subjects.

  Arzneimittel-Forschung 20100101

• Organic functionalization of single-walled carbon nanotubes (SWCNTs) with some chemotherapeutic agents as a potential method for drug delivery.

  International journal of nanomedicine 20100101

• New methods for diagnosis and treatment of vestibular diseases.

  F1000 medicine reports 20100101

• Challenges in neuro-otology.

  Frontiers in neurology 20100101

• Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: experience in the OSVaLD study.

  The international tinnitus journal 20100101

• Effect of treatment with betahistine dihydrochloride on the postural stability in patients with different duration of benign paroxysmal positional vertigo.

  The international tinnitus journal 20100101

• Spectrophotometric estimation of betahistine hydrochloride in tablet formulations.

  Journal of pharmacy & bioallied sciences 20100101

• Regulation of human umbilical artery contractility by different serotonin and histamine receptors.

  Reproductive sciences (Thousand Oaks, Calif.) 20091201

• 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.

  Journal of medicinal chemistry 20090709

• Medical treatment of vestibular disorders.

  Expert opinion on pharmacotherapy 20090701

• Current treatment of vestibular, ocular motor disorders and nystagmus.

  Therapeutic advances in neurological disorders 20090701

• Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.

  Acta oto-laryngologica 20090501

• [Menière's disease : evidence and controversies].

  HNO 20090501

• Tinnitus: characteristics, causes, mechanisms, and treatments.

  Journal of clinical neurology (Seoul, Korea) 20090301

• Frequency of ill-founded off-label prescribing in Dutch general practice.

  Pharmacoepidemiology and drug safety 20090101

• [Comparable efficacy between twice and three times daily for treatment of balance system disturbances].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20090101

• [Vestibular disorders in patients with otosclerosis: prevalence, diagnostic and therapeutic options].

  Vestnik otorinolaringologii 20090101

• Calyx and dimorphic neurons of mouse Scarpa's ganglion express histamine H3 receptors.

  BMC neuroscience 20090101

• Sudden elevation of liver enzymes in a 64-year-old patient: a case report.

  Cases journal 20090101

• An evaluation of the cost-effectiveness of booklet-based self-management of dizziness in primary care, with and without expert telephone support.

  BMC ear, nose, and throat disorders 20090101

• [Picrotoxin in the treatment of Menière's disease].

  Laryngo- rhino- otologie 20081201

• Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial.

  International journal of obesity (2005) 20081001

• [A short term study on the efficacies of intratympanic prednisolone and dexamethasone injection for subjective tinnitus].

  Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery 20081001

• Management of Ménière's disease in general practice: adherence to the UK National Health Service 'Prodigy' guidelines.

  The Journal of laryngology and otology 20080801

• Efficacy of low-level laser therapy in Ménière's disease: a pilot study of 10 patients.

  Photomedicine and laser surgery 20080801

• Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects.

  Toxicology and applied pharmacology 20080615

• Stress degradation studies on betahistine and development of a validated stability-indicating assay method.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080615

• Efficacy of a home-based exercise program on benign paroxysmal positional vertigo compared with betahistine.

  Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 20080601

• Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial.

  Acta oto-laryngologica 20080501

• Betahistine: what's new on the agenda?

  Expert opinion on investigational drugs 20080501

• Prescribing practices for Betahistine.

  British journal of clinical pharmacology 20080401

• Treating common ear problems in pregnancy: what is safe?

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20080201

• Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation.

  International journal of clinical practice 20080101

• A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study.

  Clinical drug investigation 20080101

• Case report: a case of intractable Meniere's disease treated with autogenic training.

  BioPsychoSocial medicine 20080101

• Treatment of vertebrobasilar insufficiency--associated vertigo with a fixed combination of cinnarizine and dimenhydrinate.

  The international tinnitus journal 20080101

• Multimodal therapy for chronic tinnitus.

  The international tinnitus journal 20080101

• [Frequency of dizziness-related diagnoses and prescriptions in a general practice database].

  Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 20080101

• [A sudden sensorineural hearing loss caused by a thunderbolt].

  Otolaryngologia polska = The Polish otolaryngology 20080101

• [Vestibo in the treatment of cochleovestibular disorders].

  Vestnik otorinolaringologii 20080101

• Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.

  Revue de laryngologie - otologie - rhinologie 20080101

• [Diagnostic and treatment of the vestibular apparatus diseases in the climacteric patients].

  Akusherstvo i ginekologiia 20080101

• Patient baseline characteristics in an open-label multinational study of betahistine in recurrent peripheral vestibular vertigo: the OSVaLD study.

  Current medical research and opinion 20071101

• 'Complementary ENT': a systematic review of commonly used supplements.

  The Journal of laryngology and otology 20070801

• Betahistine in the treatment of Ménière's disease.

  Neuropsychiatric disease and treatment 20070801

• Histaminergic ligands improve vestibular compensation in the cat: behavioural, neurochemical and molecular evidence.

  European journal of pharmacology 20070730

• [Frequently occurring forms of dizziness and their treatment].

  MMW Fortschritte der Medizin 20070521

• Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production.

  International immunopharmacology 20070301

• Optimizing the pharmacological component of integrated balance therapy.

  Brazilian journal of otorhinolaryngology 20070101

• Role of apolipoprotein E in anxiety.

  Neural plasticity 20070101

• [Vestibular neuritis--a case description].

  Otolaryngologia polska = The Polish otolaryngology 20070101

• [Current methods for diagnosis and treatment of iatrogenic ototoxicity].

  Vestnik otorinolaringologii 20070101

• Reversible sensorineural hearing loss in a girl with Kawasaki disease.

  The Turkish journal of pediatrics 20070101

• [Acute ear trauma caused by failure of mobile phone/cellular phone].

  Otolaryngologia polska = The Polish otolaryngology 20070101

• [Therapy of tinnitus in children].

  Otolaryngologia polska = The Polish otolaryngology 20070101

• [Comparative assessment of results in cervical vertigo pharmacotherapy vs physiotherapy treatment].

  Otolaryngologia polska = The Polish otolaryngology 20070101

• Efficacy of histaminergic drugs in experimental motion sickness.

  Journal of vestibular research : equilibrium & orientation 20070101

• Menière's disease.

  BMJ clinical evidence 20070101

• [Fluctuating deafness].

  Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris 20061201

• [Treatment costs of otogenic vertigo].

  Medizinische Klinik (Munich, Germany : 1983) 20061115

• Restoration of vestibular function: basic aspects and practical advances for rehabilitation.

  Current medical research and opinion 20060901

• Betahistine in the treatment of vertiginous syndromes: a meta-analysis.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20060801

• Betahistine increases ACh release from the cortex, but not histamine release from the nucleus basalis magnocellularis of freely-moving rats. 2. Histaminergic mechanisms in the CNS.

  Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20060401

• [Efficacy of Betahistine Mesilate combined with Flunarizine Hydrochloride for treating tinnitus].

  Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20060401

• Role of H1 receptors in histamine-mediated up-regulation of STAT4 phosphorylation.

  International immunopharmacology 20060301

• [Assessment of betahistine dihydrochloride effectiveness in the treatment of vertigo of a different aetiology based on videonystagmography test results].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20060301

• Pharmacological advances in the treatment of neuro-otological and eye movement disorders.

  Current opinion in neurology 20060201

• [Betaserc in the treatment of vestibular dysfunctions of different etiology].

  Vestnik otorinolaringologii 20060101

• Betahistine: a retrospective synopsis of safety data.

  Drug safety 20060101

• [Betaserk in therapy of cochleovestibular disordes].

  Vestnik otorinolaringologii 20060101

• [Clinical effectiveness of betahistine in monotherapy of vertigo for different etiology].

  Otolaryngologia polska = The Polish otolaryngology 20060101

• [Assessment of betahistine dihydrochloride effectiveness in the treatment of disturbance of balance system, based on analysis of doctors and patients questionnaires results].

  Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20060101

• Histamine (H3) receptors modulate the excitatory amino acid receptor response of the vestibular afferents.

  Brain research 20051207

• Menière's disease.

  Clinical evidence 20051201

• Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro.

  Neuroscience research 20051101

• [Vertigo attacks -- current therapy].

  Laryngo- rhino- otologie 20051101

• Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat.

  European journal of pharmacology 20051031

• West Nile virus infection and conjunctival exposure.

  Emerging infectious diseases 20051001

• [A clinical study on the effect of Yinxing Damo combined with betahistine hydrochloride injection on vertebral basilar artery ischemic vertigo].

  Chinese journal of integrative medicine 20050901

• Involvement of histamine H1 and H2 receptors in the regulation of STAT-1 phosphorylation: inverse agonism exhibited by the receptor antagonists.

  International immunopharmacology 20050701

• Effects of betahistine on the spatiotemporal response properties of vestibulospinal neurons to labyrinthine volleys.

  European journal of pharmacology 20050516

• Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20050401

• The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients.

  International clinical psychopharmacology 20050301

• A national survey amongst UK otolaryngologists regarding the treatment of Ménière's disease.

  The Journal of laryngology and otology 20050201

• Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-analysis of clinical trials.

  Arzneimittel-Forschung 20050101

• [Betaserc and improvement of life quality in war veterans].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• [Betaserk in the treatment of aftereffects of craniocerebral injury and vascular events].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• [Epidemiology, clinical features and betaserc therapy of vertigo in initial and reversible cerebrovascular pathology].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• [Efficacy of betaserk in experimental motor disease].

  Vestnik otorinolaringologii 20050101

• [Clinico-neurological and stabilometric analysis of betahistine (betaserc) efficacy in the patients with vertigo in the rehabilitation period of ischemic stroke].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101

• Efficacy and Tolerability of a Fixed Combination of Cinnarizine and Dimenhydrinate versus Betahistine in the Treatment of Otogenic Vertigo : A Double-Blind, Randomised Clinical Study.

  Clinical drug investigation 20050101

• Therapy of hearing disorders - conservative procedures.

  GMS current topics in otorhinolaryngology, head and neck surgery 20050101

• Procedures for restoring vestibular disorders.

  GMS current topics in otorhinolaryngology, head and neck surgery 20050101

• Meniere's disease.

  Clinical evidence 20041201

• [Delirium in a 73-year-old man after many years of unwise use of betahistine].

  Nederlands tijdschrift voor geneeskunde 20041120

• Usefulness of high doses of glucocorticoids and hyperbaric oxygen therapy in sudden sensorineural hearing loss treatment.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20041101

• Acute and clinically relevant drug-induced liver injury: a population based case-control study.

  British journal of clinical pharmacology 20040701

• Menière's disease.

  Clinical evidence 20040601

• [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].

  Vestnik otorinolaringologii 20040101

• [Rehabilitation of patients with peripheral vestibular disorders].

  Vestnik otorinolaringologii 20040101

• [Betaserc treatment of psychogenic vertigo].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

• Plasticity of histamine H3 receptor expression and binding in the vestibular nuclei after labyrinthectomy in rat.

  BMC neuroscience 20040101

• [Pharmacological correction of cochleovestibular impairments].

  Vestnik otorinolaringologii 20040101

• [A use of betaserc in ataxic syndromes].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

• Management of idiopathic sudden sensorineural hearing loss: experience in newly developing Qatar.

  The international tinnitus journal 20040101

• Investigation of Betaserc in auditory and vestibular disturbances.

  The international tinnitus journal 20040101

• Betahistine in vertebrobasilar insufficiency.

  The international tinnitus journal 20040101

• [Cerebral hemodynamics and statokinetic functions in patients with vertebral basilar vascular insufficiency].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20040101

• LC-MS-MS analysis of 2-pyridylacetic acid, a major metabolite of betahistine: application to a pharmacokinetic study in healthy volunteers.

  Xenobiotica; the fate of foreign compounds in biological systems 20031201

• Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo.

  Acta oto-laryngologica 20030601

• Menière's disease.

  Clinical evidence 20030601

• Homeopathic vs conventional treatment of vertigo.

  Archives of otolaryngology--head & neck surgery 20030401

• Influence of 3 antivertiginous medications on the vigilance of healthy volunteers.

  International journal of clinical pharmacology and therapeutics 20030401

• Evaluation of a sol-gel derived carbon composite electrode as an amperometric detector for capillary electrophoresis.

  Journal of chromatography. A 20030328

• Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.

  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20030201

• [Vestibular migraine].

  Likars'ka sprava 20030101

• [Comparative efficacy of betaserc and cinnarizine of vertigo in patients with migraine].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101

• Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea.

  Journal of vestibular research : equilibrium & orientation 20030101

• [Current approaches to the treatment of vertigo in children].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101

• [Vascular vertigo syndromes].

  Der Nervenarzt 20021201

• Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms.

  European journal of pharmacology 20020620

• Initial structure-activity relationship studies of a novel series of pyrrolo[1,2-a]pyrimid-7-ones as GnRH receptor antagonists.

  Bioorganic & medicinal chemistry letters 20020211

• Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness?

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20020201

• Menière's disease in the elderly.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20020101

• [Betaserc in symptomatic therapy of multiple sclerosis].

  Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101

• [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].

  Vestnik otorinolaringologii 20020101

• [A variant of monotherapy in vertigo and subjective noise in the ears].

  Vestnik otorinolaringologii 20020101

• Alternobaric oxygen therapy in long-term treatment of Ménière's disease.

  Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 20020101

• Histamine receptor type coupled to nitric oxide-induced relaxation of guinea-pig nasal mucosa.

  Autonomic & autacoid pharmacology 20020101

• Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.

  The international tinnitus journal 20020101

• The effect of betahistine on vestibular habituation: comparison of rotatory and sway habituation training.

  Acta oto-laryngologica 20010701

• Betahistine in the treatment of vertigo. History and clinical implications of recent pharmacological researches.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20010601

• The pharmacology of betahistine in the context of the vestibular system.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20010601

• Effects of betahistine and of its metabolites on vestibular sensory organs.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20010601

• Action mechanism of betahistine in the vestibular end organs.

  Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20010601

• Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents.

  Pharmacological research 20010401

• Betahistine for Menière's disease or syndrome.

  The Cochrane database of systematic reviews 20010101

• Pressure treatment versus gentamicin for Meniere's disease.

  Acta oto-laryngologica 20010101

• Effect of positively and negatively charged liposomes on skin permeation of drugs.

  Journal of drug targeting 20010101

• [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].

  Vestnik otorinolaringologii 20010101

• Betahistine produces post-synaptic inhibition of the excitability of the primary afferent neurons in the vestibular endorgans.

  Acta oto-laryngologica. Supplementum 20010101

• Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.

  CNS drugs 20010101

• [Menière's disease. Current status].

  Revue de laryngologie - otologie - rhinologie 20010101

• Betahistine inhibits food intake in rats.

  Polish journal of pharmacology 20010101

• Laboral outcome after acute unilateral vestibulopathy.

  Neurologia i neurochirurgia polska 20010101

• [Acute dystonia secondary to treatment with betahistine].

  Neurologia (Barcelona, Spain) 20001101

• Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.

  European journal of clinical pharmacology 19960101

• A study of the effect of betahistine on gastric acid secretion in man.

  Current medical research and opinion 19740101